Role of MyD88-dependent nuclear factor-κB signaling pathway in the development of cardiac hypertrophy in vivo

National Medical Journal of China

Volumn 85, Issue 4, 2005, Pages 267-272

  Li, Yue Hua ^a   Ha, Tuan Zhu ^b   Chen, Qi ^b   Li, Chuan Fu ^b  

^a NANJING MEDICAL UNIVERSITY   (China)

^b NONE

Author keywords

Immunoproliferation disorders; Myocardial diseases; NF B

Indexed keywords

ADENOVIRUS VECTOR; ATRIAL NATRIURETIC FACTOR; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; GREEN FLUORESCENT PROTEIN; I KAPPA B ALPHA; I KAPPA K ALPHA; I KAPPA K BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MYELOID DIFFERENTIATION FACTOR 88; NUCLEAR PROTEIN; NUCLEIC ACID BINDING PROTEIN; PLASMA PROTEIN; PLASMID VECTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING ASSAY; BODY WEIGHT; CALCULATION; CONTROLLED STUDY; FLUORESCENCE MICROSCOPY; GEL MOBILITY SHIFT ASSAY; GENE CONSTRUCT; GENE INSERTION; GENETIC TRANSFECTION; HEART VENTRICLE HYPERTROPHY; HEART WEIGHT; IN VIVO STUDY; NONHUMAN; PATHOGENESIS; PROTEIN EXPRESSION; PROTEIN ISOLATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; RAT; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADENOVIRIDAE; ANIMALS; ANTIGENS, DIFFERENTIATION; ATRIAL NATRIURETIC FACTOR; CARDIOMEGALY; MALE; MYELOID DIFFERENTIATION FACTOR 88; MYOCARDIUM; NF-KAPPA B; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, IMMUNOLOGIC; SIGNAL TRANSDUCTION; TRANSFECTION; XENOPUS PROTEINS;

EID: 21644450549     PISSN: 03762491     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Purcell NH, Molkentin JD. Is nuclear factor κB an attractive therapeutic target for treating cardiac hypertrophy. Circulation, 2003,108:638-640.
2. Li YH, Ha TZ, Gao X, et al. NF-kappa B activation is required for the development of cardiac hypertrophy in vivo. Am J Physiol Heart Circ Physiol, 2004, 287:H1712-H1720.
3. Zhang G, Ghosh S. Toll-like receptor-mediated NF-kB activation: a phylogenetically conserved paradigm in innate immunity. J Clin Invest, 2001,107: 13-19.
4. Medzhitov R, Preston-Hurlburt P, Kopp E, et al. MyD88 is an adaptor protein in the hToll/Il-1 receptor family signaling pathways. Mol Cell, 1998, 2:253-258.
5. Burns K, Martinon F, Esslinger C, et al. MyD88, an adapter protein involved in interleukin-1 signaling. J Biol Chem, 1998, 273: 12203-12209.
6. Baeuerle PA, Baltimore D. NF-kB: ten years after. Cell, 1996, 87: 13-20.
7. Dupraz P, Cottet S, Hamburger F, et al. Dominant negative MyD88 proteins inhibit interleukin-1b/interferon-g-mediated induction of nuclear factor kB-dependent nitrite production and apoptosis in b cells. J Biol Chem, 2000, 275:37672-37678.
8. Adams JW, Sakata Y, Davis MG, et al. Enhanced Gaq signaling: a common pathway mediates cardiac hypertrophy and apoptotic heart failure. Proc Natl Acad Sci USA, 1998, 95:10140-10145.
9. Passier R, Zeng H, Frey N, et al. CaM kinase signaling induces cardiac hypertrophy and activates the MEF2 transcription factor in vivo. J Clin Invest, 2000, 105: 1395-1406.